World Library  
Flag as Inappropriate
Email this Article

Dirofilaria repens

Article Id: WHEBN0022834546
Reproduction Date:

Title: Dirofilaria repens  
Author: World Heritage Encyclopedia
Language: English
Subject: Dirofilaria immitis, Dirofilariasis, Dirofilaria
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Dirofilaria repens

Dirofilaria repens
Scientific classification
Kingdom: Animalia
Subkingdom: Eumetazoa
(unranked): Bilateria
Superphylum: Platyzoa
Phylum: Nematoda
Class: Secernentea
Subclass: Spiruria
Order: Spirurida
Family: Onchocercidae
Genus: Dirofilaria
Species: D. repens
Binomial name
Dirofilaria repens

Dirofilaria repens is a filarial nematode that affects dogs and other carnivores such as cats, wolves, coyotes, foxes, muskrats and sea lions. Although humans may become infected as aberrant hosts, the worms fail to reach adulthood while residing in a human body.

Epidemiology

It most often found in the Mediterranean region, sub-Saharan Africa, and Eastern Europe. Italy bears the highest burden of European Dirofilariasis cases in humans: (66%), followed by France (22%), Greece (8%), and Spain (4%).

Life Cycle

The life cycle of Diroflaria repens consists of five larval stages in a vertebral host and an arthropod (mosquito) intermediate host and vector. In the first stage, mated adult female worms produce thousands of microfilariae (larvae) into the circulation daily, which are ingested by mosquitoes in a blood meal. Larvae develop into infective larvae within the mosquito over the next 10–16 days, depending on environmental conditions, before being reintroduced back into a new host.[1] Microfilariae undergo secondary developmental changes in the insect. For the final two stages of development, third-stage larvae are inoculated back into a vertebral host during an act of feeding. The adults of D. repens reside in the subcutaneous tissues of dogs and cats, where they mature in 6–7 months. Adult worms are 1–2 mm in diameter (females are 25–30 cm in length, the males being shorter).

Humans are accidental hosts because adult worms can not reach maturity in the heart or in the skin. Most infective larvae introduced into humans are thought to die; therefore, infected individuals usually are not microfilaremic. Human disease is amicrofilaremic.

Infections in Humans

Retroocular nodule of a Dirofilaria repens worm detected in a 20-year-old woman, Rostov-na-Donu, Russia. The cyst (arrows) is shown by computed tomography scan (A) and magnetic resonance imaging (B). Ultrasonography image (C) shows a worm-like structure inside the cyst (arrow), and color Doppler imaging (D) shows marginal vascularization of the lesion).

Infections in humans [2] usually manifests as a single subcutaneous nodule, which is caused by a macrofilaria that is trapped by the immune system. Subcutaneous migration of the worm may result in local swellings with changing localization. In addition, rare cases of organ manifestation have been reported, affecting the lung, male genitals, female breast or the eye. The latter is found in particular during the migratory phase of the parasite. D. repens occurs more commonly in adults (aged 40–49 years). The only exception is in Sri Lanka, where children younger than 9 years are most likely to be infected. The youngest individual reported was aged 4 months.[3]

Diagnosis

Final diagnosis is established by microscopic examination of the excised worm. Making a definite species diagnosis on morphologic grounds is difficult, because a large number of zoonotic Dirofilaria species have been described that share morphologic features with D. repens.

Treatment

Antifilarial medication for infected humans generally is not supported in the medical literature.[1] One group of authors has recommended a single dose of Ivermectin followed by 3 doses of diethylcarbamazine (DEC) if the syndrome is recognized prior to surgery. However, most cases are diagnosed retrospectively, when histopathological sections of biopsy or excision material are viewed. In term of surgical care, excision of lesions and affected areas is the treatment of choice for patients with human dirofilariasis. Some authors have recommended a period of observing chest coin lesions for several months if dirofilariasis is suspected and no other features in the history or examination suggesting malignancy or other infection are present. Also no specific diet is recommended for patients with dirofilariasis.

References

  1. ^ a b "Dirofilariasis", Author: Michael D Nissen, MBBS, BMedSc, FRACP, FRCPA, Associate Professor in Biomolecular, Biomedical Science & Health, Griffith University; Director of Infectious Diseases and Unit Head of Queensland Paediatric Infectious Laboratory, Sir Albert Sakzewski Viral Research Centre, Royal Children's Hospital Coauthor(s): John Charles Walker, MSc, PhD, Head, Department of Parasitology, Center for Infectious Diseases and Microbiology, Westmead Hospital, Westmead, Australia; Senior Lecturer, Department of Medicine, University of Sydney, Australia
  2. ^ "Dirofilaria repens Infection and Concomitant Meningoencephalitis", by Sven Poppert, Maike Hodapp, Andreas Krueger, Guido Hegasy, Wolf-Dirk Niesen, Winfried V. Kern, and Egbert Tannich.
  3. ^ Schmidt.GD, Robert.LS (2009). Foundations of Parasitology. New York, New York. McGraw-Hill Companies, Inc.
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.